News

The American Society of Cataract and Refractive Surgery (ASCRS) held it's annual meeting May 5-8, 2023 in San Diego, California.

Lloyd Williams, MD, PhD, Duke Global Ophthalmology Program Director and cornea surgeon shares his passion for curing blindness around the world – he's made it his life's mission.

The annual meeting for the Association of Research in Vision and Ophthalmology (ARVO) will be held April 23-27 in New Orleans, LA. There will be 100 presentations by Duke faculty and trainees.

Professor of Ophthalmology and Glaucoma Division Chief, Leon Herndon, MD was among the honorees named on the 2023 The Ophthalmologist "Power List".  

Duke Eye Center recently hosted the Annual Duke Fellows’ Advanced Vitreous Surgery Course (fAVS) and prestigious Duke Advanced Vitreous Surgery Course (AVS) led by course director Lejla Vajzovic MD, FASRS along with co-chairs, Dilraj S. Grewal, MD, FASRS, Xi Chen, MD, PhD, and Durga S. Borkar, MD, MMCi.

The American Association of Pediatric Ophthalmology and Strabismus (AAPOS) held it's annual meeting March 29 – April 2, 2023 in New York City, New York.  

Congratulations to Sidney Gospe III, MD, PhD for receiving the Pilot Research Grant Award for his work on "Reducing neuro-inflammation in a mouse model of mitochondrial optic neuropathy". This award was announced at the annual North American Neuro-ophthalmology Society (NANOS) meeting that took place in Orlando, Florida March 2023.  

Sri Meghana Konda, MD PGY 3  and James Tian, MD  PGY4 were 2 of 10 ophthalmology residents honored with the 2023 Resident Excellence Award, presented by the American Society of Cataract and Refractive Surgery (ASCRS) Foundation. 

Leon Herndon, MD, professor of ophthalmology and glaucoma division chief was named President of the American Glaucoma Society (AGS) for 2023-2024 at the conclusion of the annual meeting held March 2-5 in Austin, Texas. Herndon has been an active member of AGS, previously serving in various leadership roles, on the board of directors, and most recently vice president from 2022-2023.

On February 17, 2023, the U.S. Food and Drug Administration (FDA) approved a groundbreaking treatment to treat geographic atrophy (GA), an advanced form of dry macular degeneration (AMD). Eleonora Lad, MD, PhD, director of clinical research and associate professor, was a lead investigator in the OAKS trial, a pivotal clinical trial that supported the FDA approval.